🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
This is an open-label, single-arm, multicentre, global, phase II study desi...
Status
Completed
Location
Research Site
Start Date
2014-04-30
Trial ID
NCT02127710
Treatments Being Tested
This study will be conducted to quantify the magnitude of the effect of itr...
Status
Completed
Location
Research Site
Start Date
2019-11-07
Trial ID
NCT04121910
Treatments Being Tested
This will be an open-label, randomised, 2 part (Part A and Part B), 2 treat...
Status
Completed
Location
Research Site
Start Date
2019-12-13
Trial ID
NCT04179071
Treatments Being Tested
Osimertinib combined with savolitinib in the treatment of EGFR mutated osim...
Status
Recruiting
Location
Qingdao Central Hospital
Start Date
2025-01-01
Trial ID
NCT07322783
Treatments Being Tested
Volitinib is a potent and selective small molecule c-Met kinase inhibitor. ...
Status
Completed
Location
Samsung Medical center
Start Date
2016-02-10
Trial ID
NCT02449551
Treatments Being Tested
Clinical study to investigate the efficacy and safety of savolitinib in com...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-08-03
Trial ID
NCT05261399
Treatments Being Tested
For patients who failed primary chemotherapy with MET amplification, The ef...
Status
Recruiting
Location
Samsung Medical Center
Start Date
2023-01-05
Trial ID
NCT05620628
Treatments Being Tested
This is a prospective, pilot, single-arm, single-center study exploring the...
Status
Recruiting
Location
Department of Thoracic Surgery and Oncology, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2023-07-26
Trial ID
NCT05777278
Treatments Being Tested
The Sponsor is developing the test medicine, AZD6094 (Savolitinib) for the ...
Status
Completed
Location
Research Site
Start Date
2020-11-13
Trial ID
NCT04675021